BackGenerate Biomedicines Overview

Generate Biomedicines Accounts Payable

Generate Biomedicines's accounts payable is $5.7M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$5.65M

Peer trimmed avg / median

Loading

Generate Biomedicines Accounts Payable History

Loading

Generate Biomedicines vs. peers: Accounts Payable Comparison

Loading

Generate Biomedicines Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Generate Biomedicines (GENB) FAQ

As of the most recent data (June 2026), GENB shows a accounts payable of $5.7M. Scroll down for historical charts and peer comparison views.

Tracking GENB's accounts payable over time shows whether Generate Biomedicines is scaling, shrinking, or reshaping that part of the business. The current reading is $5.7M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Generate Biomedicines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $5.7M) with ownership activity and broader fundamentals.